CA
NZ
UK
AU
IND
US
Spyre Therapeutics (NASDAQ:SYRE) shares closed up 10.54% at $104.94, a fresh 52-week high, with a day range of $97.03 to $105.23 on volume of 818,350 shares, sharply outperforming the broader healthcare sector after the company reported positive Phase 2 trial data and provided a …
AstraZeneca (NYSE:AZN) shares closed down 1.49% at $155.62, with a day range of $155.33 to $158.56 on volume of 8.05 million shares, as reports confirmed that merger talks with Bristol Myers Squibb remain active, following the initial Financial Times report of preliminary discussions.
Inspire Medical Systems (NYSE:INSP) shares surged 22.83% to close at $64.14, with a day range of $59.50 to $66.21 on volume of 2.30 million shares, after the medical device maker reported second-quarter results that topped subdued expectations.
TELA Bio (NASDAQ:TELA) shares closed up 22.51% at $0.91, with a day range of $0.68 to $0.93 on volume of 731,730 shares, after the company announced that its board of directors has appointed Heather Getz as Chief Executive Officer and Director, effective immediately.
Bausch Health (NYSE:BHC) shares closed down 8.00% at $6.44, with a day range of $6.36 to $7.05 on volume of 12.10 million shares. No new macro, sector, or company-specific catalysts were identified for the decline today, suggesting the move reflects profit-taking and consolidation after …
ORIC Pharmaceuticals (NASDAQ:ORIC) shares surged 27.08% to close at $13.47, with a day range of $10.64 to $13.73 on volume of 4.98 million shares, after the company reported second-quarter financial results and provided operational updates highlighted by the initiation of a pivotal Phase 3 …
Adagio Medical Holdings (NASDAQ:ADGM) shares closed up 76.11% at $0.81, with a day range of $0.55 to $1.13 on volume of 467.24 million shares, after the company announced the successful treatment of the first patient with its next-generation vCLAS Ultra system.
Bruker (NASDAQ:BRKR) shares plunged 21.79% to close at $50.30, with a day range of $50.14 to $56.37 on volume of 8.82 million shares, after the company's second-quarter report revealed a lowered full-year revenue guidance range that overshadowed an otherwise mixed quarter.
Pfizer (NYSE:PFE) shares closed up 1.52% at $25.41, with a day range of $24.70 to $25.64 on volume of 55.42 million shares, after the company reported second-quarter results that beat Wall Street expectations on both revenue and earnings.
Amgen (NASDAQ:AMGN) shares closed up 2.94% at $390.02, with a day range of $376.02 to $390.95 on volume of 3.46 million shares, after the company delivered a strong second-quarter earnings beat that exceeded both revenue and profit expectations.
Please wait processing your request...